CPHI vs NOC · rev $4.1M vs P/E 17, rev $41.95B
China Pharma Holdings Inc (CPHI) versus Northrop Grumman Corporation (NOC) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Northrop Grumman Corporation (NOC) is a aerospace & defense company listed on NYSE.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported NOC revenue for 2025-12-31 was $41.95B. Net income was $4.18B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. NOC currently screens at market cap $78.14B and trailing P/E 17.2.
CPHI currently screens at market cap $29.0M. NOC currently screens at market cap $78.14B and trailing P/E 17.2.
Not investment advice. Open the CPHI and NOC stock pages for the full models.
Not investment advice.